Literature DB >> 24980570

Confusion of therapeutic approaches. In reply.

Axel Schlitt.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24980570      PMCID： PMC4078233          DOI： 10.3238/arztebl.2014.0405b

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

Review 1.  Cardiovascular effects of tyrosine kinase inhibitors used for gastrointestinal stromal tumors.

Authors:  Vishnu Chintalgattu; Shalin S Patel; Aarif Y Khakoo
Journal:  Hematol Oncol Clin North Am       Date:  2009-02       Impact factor: 3.722

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

3.  Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma.

Authors:  Manuela Schmidinger; Christoph C Zielinski; Ursula M Vogl; Andja Bojic; Marija Bojic; Christoph Schukro; Marquerite Ruhsam; Michael Hejna; Herwig Schmidinger
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

Review 4.  Cardiotoxicity and oncological treatments.

Authors:  Axel Schlitt; Karin Jordan; Dirk Vordermark; Jürgen Schwamborn; Thorsten Langer; Christoph Thomssen
Journal:  Dtsch Arztebl Int       Date:  2014-03-07       Impact factor: 5.594
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.